Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 63,723 | 58,443 | 51,494 | 43,522 | 17,403 |
| Cost of Goods | 5,626 | 5,281 | 4,540 | 4,406 | 2,083 |
| Gross Profit | 58,097 | 53,162 | 46,954 | 39,116 | 15,320 |
| Operating Expenses | 230,504 | 135,825 | 126,148 | 117,559 | 78,250 |
| Operating Income | -171,781 | -82,382 | -78,654 | -78,037 | -62,847 |
| Interest Expense | 13,577 | 11,338 | 7,022 | 6,671 | 6,768 |
| Other Income | -8,148 | 12,986 | 14,638 | 78,155 | -86,021 |
| Pre-tax Income | -193,506 | -80,734 | -71,038 | -6,553 | -155,636 |
| Net Income Continuous | -193,506 | -80,734 | -71,038 | -6,553 | -155,636 |
| Net Income | $-193,506 | $-80,736 | $-71,038 | $-6,553 | $-155,636 |
| EPS Basic Total Ops | -1.22 | -1.01 | -0.92 | -0.09 | -2.56 |
| EPS Basic Continuous Ops | -1.22 | -1.01 | -0.92 | -0.09 | -2.56 |
| EPS Diluted Total Ops | -1.22 | -1.02 | -0.97 | -0.98 | -2.56 |
| EPS Diluted Continuous Ops | -1.22 | -0.94 | -0.86 | -0.08 | -2.56 |
| EPS Diluted Before Non-Recurring Items | -1.08 | -1.13 | -0.97 | -0.98 | -1.14 |
| EBITDA(a) | $-167,995 | $-79,399 | $-76,545 | $-75,616 | $-60,074 |